back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-08 13:47 Tx date 2026-06-02 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,560
+16,800 vol $1.70 each |
821,715 | |
| Filed 2026-01-06 16:07 Tx date 2026-01-02 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-250,000 vol |
0 | |
| Filed 2026-01-06 15:54 Tx date 2026-01-02 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$546,875
+312,500 vol $1.75 each |
804,915 | |
| Filed 2025-08-31 23:50 Tx date 2025-08-28 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,160,000
+1,500,000 vol $1.44 each |
4,350,000 | |
| Filed 2025-04-07 17:30 Tx date 2025-01-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-250,000 vol |
250,000 | |
| Filed 2025-04-07 17:25 Tx date 2025-01-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
492,415 | |
| Filed 2024-12-19 16:21 Tx date 2024-12-12 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,599
+10,704 vol $0.71 each |
242,415 | |
| Filed 2024-12-02 13:10 Tx date 2024-11-28 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+15,000 vol $0.75 each |
231,711 | |
| Filed 2024-11-26 14:45 Tx date 2024-11-22 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+250,000 vol |
500,000 | |
| Filed 2024-07-27 15:32 Tx date 2024-07-26 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,349
+3,916 vol $0.60 each |
216,711 | |
| Filed 2024-05-07 22:54 Tx date 2024-05-07 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,280
+3,000 vol $0.76 each |
212,795 | |
| Filed 2023-12-10 19:53 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,970
+22,700 vol $1.10 each |
209,795 | |
| Filed 2023-12-10 19:50 Tx date 2023-12-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2023-12-10 19:48 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-10 19:44 Tx date 2023-12-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+250,000 vol $1.20 each |
2,850,000 | |
| Filed 2023-12-10 19:40 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,250,000
+1,250,000 vol $1.80 each |
2,600,000 | |
| Filed 2023-12-10 19:39 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$750,000
+750,000 vol $1.00 each |
1,350,000 | |
| Filed 2023-12-10 19:39 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+250,000 vol $1.80 each |
600,000 | |
| Filed 2023-12-10 19:38 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2023-12-10 19:38 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,970
+22,700 vol $1.10 each |